Related Experiment Video
Updated: Feb 22, 2026

08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
11.0K
High-throughput flow cytometry for drug discovery: principles, applications, and case studies
Mei Ding1, Karin Kaspersson1, David Murray2
1Discovery Sciences, Innovative Medicines and Early Development, AstraZeneca, Pepparedsleden 1, SE-43183 Mölndal, Sweden.
Drug Discovery Today
|September 17, 2017
Summary
High-throughput flow cytometry offers powerful multiparametric analysis for drug discovery screening. This review details its applications and practical considerations for assay development, highlighting its value in accelerating the drug discovery process.
Area of Science:
- Biotechnology
- Analytical Chemistry
- Pharmacology
Background:
- Flow cytometry enables multiparametric analysis of single cells.
- High-throughput (HT) flow cytometry is increasingly used for drug discovery screening.
Purpose of the Study:
- To review recent applications of HT flow cytometry in drug discovery.
- To focus on the deployment and practical considerations of HT flow cytometry at AstraZeneca (AZ).
- To illustrate how HT flow cytometry assays support the drug discovery process.
Main Methods:
- Review of recent literature on HT flow cytometry applications.
- Case studies from four drug discovery projects at AstraZeneca.
- Analysis of practical considerations for assay development and screening.
Main Results:
- HT flow cytometry provides a valuable screening platform for drug discovery.
- Successful assay development and screening require careful practical considerations.
- HT flow cytometry assays offer novel approaches to support drug discovery.
Conclusions:
- HT flow cytometry is a key technology for modern drug discovery.
- AstraZeneca's experience demonstrates the successful implementation of HT flow cytometry.
- Best practices for HT flow cytometry assay development enhance its utility in drug discovery.

